Stock Earnings

Question 1

What are Inhibikase Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Inhibikase Therapeutics Inc has a total asset of $98, Net loss of $-27

Question 2

What are the key financial ratios for IKT?

Accepted Answer

Inhibikase Therapeutics Inc's Current ratio is 32.66, has a Net margin is 0, sales per share of $0.

Question 3

How is Inhibikase Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Inhibikase Therapeutics Inc largest revenue segment is Protein Kinase Inhibitor Therapeutics, at a revenue of 260,500 in the most earnings release.For geography, United States is the primary market for Inhibikase Therapeutics Inc, at a revenue of 260,500.

Question 4

Is Inhibikase Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Inhibikase Therapeutics Inc has a net loss of $-27

Question 5

Does Inhibikase Therapeutics Inc have any liabilities?

Accepted Answer

yes, Inhibikase Therapeutics Inc has liability of 3

Question 6

How many outstanding shares for Inhibikase Therapeutics Inc?

Accepted Answer

Inhibikase Therapeutics Inc has a total outstanding shares of 69.36

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	3	0
Revenue Growth (YoY)	--	--	--	-100%	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	22	11	6	6	6	2
Research & Development	30	17	13	12	11	0
Operating Expenses	51	28	20	18	17	3
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-47	-27	-19	-18	-14	-2
Income Tax Expense	0	--	--	--	--	--
Net Income	-47	-27	-19	-18	-14	-2
Net Income Growth	147%	42%	6%	28.99%	600%	-60%
Shares Outstanding (Diluted)	90.05	23.71	5.33	4.2	4.19	1.37
Shares Change (YoY)	914%	345%	27%	0%	206%	-12%
EPS (Diluted)	-0.52	-1.16	-3.56	-4.3	-3.53	-2.08
EPS Growth	-76%	-67%	-17%	22%	70%	-43%
Free Cash Flow	-25	-19	-18	-17	-14	-1
Free Cash Flow Per Share	-0.27	-0.8	-3.37	-4.04	-3.34	-0.72
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	-466.66%	0%
Profit Margin	0%	0%	0%	0%	-466.66%	0%
Free Cash Flow Margin	0%	0%	0%	0%	-466.66%	0%
EBITDA	-51	-28	-20	-18	--	--
EBITDA Margin	0%	0%	0%	0%	--	--
D&A For EBITDA	0	0	0	0	--	--
EBIT	-51	-28	-20	-18	-14	-2
EBIT Margin	0%	0%	0%	0%	-466.66%	0%
Effective Tax Rate	0%	--	--	--	--	--

Inhibikase Therapeutics Inc (IKT) Price

IKT Stock Price Chart

IKT Income

Follow-Up Questions